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miRNA let-7e targeting MMP9 is involved in adipose-
derived stem cell differentiation toward epithelia
M Ventayol1, JL Vin˜as1, A Sola1,2, M Jung3, B Bru¨ne3, F Pi1, C Mastora1 and G Hotter*,1,2
miRNA let-7e is involved in stem cell differentiation, and metalloproteinases are among its potential target genes.
We hypothesized that the inhibitory action of let-7e on regulation of MMP9 expression could represent a crucial mechanism
during differentiation of adipose-derived stem cells (ASCs). ASCs were differentiated with all-trans retinoic acid (ATRA) to
promote differentiation, and the effect of let-7 silencing during differentiation was tested. Results indicate that ASCs cultured
with ATRA differentiated into cells of the epithelial lineage. We found that ASCs cultured with ATRA or transfected with miRNA
let-7e expressed epithelial markers such as cytokeratin-18 and early renal organogenesis markers such as Pax2, Wt1, Wnt4 and
megalin. Conversely, the specific knockdown of miRNA let-7e in ASCs significantly decreased the expression of these genes,
indicating its vital role during the differentiation process. Using luciferase reporter assays, we also showed that MMP9 is a direct
target of miRNA let-7e. Thus, our results suggest that miRNA let-7e acts as a matrix metalloproteinase-9 (MMP9) inhibitor and
differentiation inducer in ASCs.
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Adipose-derived stem cells (ASCs) are attractive targets for
clinical applications. They offer multiple advantages such as
good accessibility, abundance and the ability to expand in
culture,maintaining their multilineage differentiation potential.1,2
Under the appropriate stimulus, ASCs differentiate into cells
with characteristics of hepatocytes,3 neurons,4 endothelial
cells5 and/or renal epithelial cells.6
ASCs mainly express a mesenchymal cellular phenotype,
and their differentiation toward cells with epithelial characteri-
stics requires extensive alterations in gene expression.
Interestingly, it has been shown that the in vitro process of
differentiation toward renal epithelial cells is phenotypically
almost identical to the one that occurs during renal organo-
genesis, in terms of both morphology and specific protein
expression patterns.7 Differentiation of organs demands a
mesenchymal-to-epithelial transition (MET), a coremechanism
that allows cells to acquire a specific lineage-determined
phenotype. Cellular changes associated with MET include
major changes in the expression of several genes related to
the conversion of the extracellular matrix,8 such as matrix
metalloproteinases9,10 and the redistribution of the cytoske-
letal structure, finally leading to the establishment of the
typical apical–basal polarity of epithelial cells. These morpho-
logical changes result from a specific expression profile of
surface markers, transcription factors and microRNAs
(miRNAs).
The miRNAs are small (B22 nt), regulatory, noncoding
RNA molecules that control the expression of their target
mRNAs at the post-transcriptional level by binding to the 30-
untranslated region (30UTR). There is a well-established
biotechnology system for studying the role and targets of
miRNAs in vitro and also in vivo. Using synthetic miRNAs
and transfection methods, we can mimic or suppress the
action of specific miRNAs and study the consequences in
different models. The miRNAs are involved in the differ-
entiation of diverse cell lineages—among others, skeletal
muscle cells,11 cardiomyocytes12 and neurons.13 Interest-
ingly, critical signaling pathways during differentiation, such
as the Wnt pathway,14 are mainly controlled by the
expression of specific miRNAs. miRNA family let-7 (let-7)
is considered as a global regulator of differentiation.15 The
let-7 is barely detected during embryonic development, but it
increases significantly as tissues differentiate and it is
mainly detected in the adult kidney.16 In addition, let-7e
plays a pivotal role in stem cell differentiation,17,18 and its
loss results in reversion of embryogenesis and dediffer-
entiation. Decreased levels of miRNA let-7e have also been
associated with metastasis and poor prognosis in renal cell
carcinoma,19 possibly because of its effects on matrix
metalloproteinases (MMPs). It has previously been shown
that miRNA let-7b downregulates MMP9 activity through
indirect effects by inhibition of basigin.20,21 By using in silico
analysis of the 30UTR of MMP9, a predicted binding site of
miRNA let-7e was indicated.22 Nevertheless, the direct
effect of miRNA let-7e on MMP9 expression has not been
investigated to date.
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Thus, asmiRNA let-7e adopts a pivotal role during stem cell
differentiation, and MMP9 may be a potential direct let-7e
target, we hypothesized that the inhibitory action of let-7e on
the regulation of MMP9 expression could represent a crucial
mechanism during renal organogenesis. In this studywe show
that let-7e is induced during renal epithelial cell differentiation
from ASCs and that the direct inhibition of MMP9 by miRNA
let-7e plays a key role during this process.
Results
ASCs have multilineage potential and phenotypical
characteristics of mesenchymal stem cells. ASCs
obtained from male Swiss CD1 mice were isolated and
expanded in vitro in control media. In order to confirm their
multilineage potential, these cells were cultured with adipo-
genic media for 15 days and with osteogenic media for 20
days. ASCs cultured under adipogenic conditions formed
lipid vacuoles that are considered to be typical features of the
adipogenic lineage (Figure 1a, left panel). ASCs cultured
under osteogenic conditions showed depositions of miner-
alized matrix, a characteristic of the osteogenic lineage
(Figure 1a, right panel). These observations confirmed the
multilineage potential of ASCs. Cellular composition was
analyzed by flow cytometry (Figure 1b). Approximately 90%
of the population was positive for the mesenchymal stem cell
markers CD44, Sca-1 and CD29, and negative for CD34 and
CD45.
ATRA promotes morphological differentiation of ASCs.
Phase-contrast microscopy analysis of ASCs cultured with
5mM all-trans retinoic acid (ATRA) for 11 days showed a
gradual conversion into a more epithelial polygonal pheno-
type with respect to untreated controls (Figure 1c, upper
panel). A flattened fibroblast-like morphology was observed
in untreated cells, whereas ATRA stimulation gradually
changed cell morphology into an epithelial, cobblestone-like
phenotype. Changes in cytoskeletal organization were
assessed by immunofluorescence staining of the actin fiber
network (Figure 1c, lower panel). Cells showed an organized
cytoskeletal network with dense actin fibers at the edges
when cultured with ATRA for 11 days. Untreated controls
maintained the equal actin fiber distribution throughout the
whole cell, typical of the mesenchymal phenotype.
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Figure 1 Multilineage potential and mesenchymal stem cell phenotype of mouse ASCs. (a) Oil red staining after 15 days of culture in adipogenic media (left panel).
A representative image from five independent experiments is illustrated. Magnification  20. Alizarin red staining after 20 days of culture in osteogenic media (right panel).
A representative image from five independent experiments is illustrated. Magnification  20. (b) ASCs were positive for Sca-1, CD44 and CD29, and negative for CD34 and
CD45, confirming their mesenchymal origin. (c) Morphological representation of mesenchymal-to-epithelial transition. Phase-contrast images representative of ASC
morphology change during the differentiation protocol. ASCs were left untreated or differentiated with ATRA for 6 or 11 days (upper panel). Representative images from four
independent experiments are illustrated. Magnification  20. Phalloidin staining of f-actin cytoskeleton (in red) contributes to visualize the epithelial-like morphology (day 11) in
contrast to the more fibroblast-like morphology of untreated, undifferentiated cells. Nuclei were stained with DAPI (in blue) and images obtained by fluorescence microscopy.
A representative picture from four independent experiments is shown. Magnification  40
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ATRA promotes differentiation of ASCs toward the
epithelial lineage. Upregulation of Pax2, an intermediate
mesoderm marker, and also upregulation of WT1, Wnt4, Six2
and megalin, all markers of the metanephric mesenchyme,
were observed when ASCs were cultured in media with a
physiological concentration of glucose and supplemented
with ATRA (Figure 2).
ASCs also showed a significant induction of the epithelial
markers cytokeratin-18 (CK18) and E-cadherin (E-CAD),
whereas mRNA expression of vimentin, a classical mesench-
ymal marker, was downregulated (Figure 3). Expression of
CK18 was also confirmed by immunocytochemistry (Figure 3).
CK18 appeared as a perinuclear brown staining when ASCs
were cultured for 11 days under differentiation conditions. In
contrast, untreated ASCs showed no CK18 staining.
miRNA let-7e is upregulated in ASC differentiation and is
involved in the expression of early nephrogenic and
epithelial markers. In order to evaluate the role of miRNA
let-7e in ASC differentiation, ASCs were transfected
with 100 nM miRNA let-7e at day 2 of culture and collected
at day 6.
ASCs were also differentiated with ATRA and transfected
with anti-miRNA let-7e for knockdown at day 4 and
collected at day 6. As we wanted to test the effect of let-
7e knockdown on differentiation markers, which did not
show a significant increase until day 4 of differentiation
(see Figure 2), this particular time point was chosen to
deliver anti-miRNA let-7e. A schematic overview is given
in Figure 4.
The expression of miRNA let-7e (Figure 4) and nephrogenic
markers (Figure 5) was evaluated. The miRNA let-7e
transfection significantly upregulated let-7e expression and
induced the expression of the metanephric mesenchyme
markers Pax2,Wnt4,Wt1 andmegalin as well as the epithelial
marker CK18. In contrast, miRNA let-7e knockdown blocked
the increase in early nephrogenic and epithelial markers
observed during ASC differentiation with ATRA.
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Figure 2 ATRA stimulation of ASCs promotes overexpression of early nephrogenic markers. qRT-PCR analysis of early nephrogenic markers PAX2, WT1, Wnt4, Six2
and megalin. Total RNA was extracted from ASCs cultured for 1 to 11 days with ATRA (black columns) or with control medium (gray columns). A sample of ASCs on day 0 was
analyzed as control; n¼ 4. Data are means±S.D. *Po0.05 versus untreated
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miRNA let-7e targets the 30UTR of MMP9. The over-
expression of miRNA let-7e in ASCs cultured under
untreated conditions provoked the downregulation of MMP9
mRNA expression (Figure 6a). MMP9 activity was also
reduced, as observed in zymographic gels. Both pro-form
and active MMP9 were downregulated compared with
untreated controls (Figure 6b).
In order to determine whether MMP9 was regulated by let-
7e through direct binding of the miRNA to the 30UTR, we
transfected either a control vector (control), a wild-type
construct (30UTR-MMP9) with an intact let-7e-binding site or
the mutated construct (30UTR-mutMMP9) in HEK293 cells
(Figure 6c). We chose HEK293 because this cell type can be
transfected very easily and is a good starting point for
experiments that include luciferase constructions and
co-transfection with miRNAs. Cells were co-transfected with
either control miRNA (C) or miRNA let-7e (þ let-7e).
Luciferase activity showed a significant decrease in cells
treated with let-7e, suggesting that let-7e binds to the 30UTR
of MMP9. In contrast, the mutation of the let-7e-binding site in
the 30UTR of MMP9 led to an increase in luciferase activity,
confirming the involvement of let-7e in MMP9 inhibition.
Similar results were found using ASCs under untreated
conditions (Figure 6d). Co-transfection of let-7e in undiffer-
entiated ASCs reduced luciferase activity using the wild-type
reporter construct for the 30UTR ofMMP9 containing the intact
let-7e-binding site. To confirm these data, we used ASCs
differentiated with ATRA for 8 days and co-transfected the
cells with either anti-let-7e or a control antimiR. The data
showed a significant increase in luciferase activity by blocking
let-7e during differentiation. These results further corroborate
the notion that let-7e has a regulatory effect on MMP9
expression.
We also checked whether the increased expression of
MMP9 provoked by miRNA let-7e silencing was directly
correlated with MMP9 activity. In situ zymography experi-
ments were performed and gelatinolytic activity was mea-
sured according to the levels of fluorescence emitted through
digestion of FITC-labeled gelatine (Figure 7a). The results
showed increased gelatinase activity when miRNA let-7e was
blocked. Finally, we tested the role of MMP9 on epithelial cell
features by assessing E-cadherin expression (Figure 7b).
Both ASCs (left panel) and NRK-52e cells, an established
kidney tubular epithelial cell line (right panel), were used to
detect E-cadherin expression by western blot analysis. ASCs
treated with ATRA showed a significant increase in E-cad-
herin expression compared with untreated cells. This increase
was blocked by the addition of recombinant MMP9. The same
results were obtained when using NRK-52e cells, thus
confirming the inhibitory effect of MMP9 on epithelial cell
characteristics.
Discussion
ASCs are pluripotent cells that can differentiate mainly into
cells of the same lineage commitment, such as osteocytes,
chondrocytes and adipocytes.23 Nevertheless, various
studies proposed that ASCs can overcome this lineage
commitment and differentiate into renal epithelia. Renal
epithelial differentiation of ASCs was first observed after
transplantation of human ASCs into ischemic mouse kidneys.
ASCs were readily integrated into the tissue and differentiated
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Figure 3 ATRA stimulation of ASCs promotes epithelial differentiation. qRT-PCR analysis of epithelial markers CK18 and E-CAD and the mesenchymal marker vimentin.
Total RNA was extracted from ASCs cultured for 1 to 11 days with ATRA (black columns) or with control medium (gray columns). A sample of ASCs on day 0 was analyzed as
control. n¼ 4. Data are means±S.D. *Po0.05 versus untreated. Immunocytochemistry of the epithelial marker CK18. A perinuclear gray area in ASCs cultured for 11 days
was observed after incubation with ATRA (day 11). No staining was observed in untreated cells. Nuclei were hematoxylin stained. A representative image from four
independent experiments is shown. Magnification  40
let-7e and MMP9 in ASC differentiation
M Ventayol et al
4
Cell Death and Disease
into epithelial-like cells, as corroborated by the expression of
CK18.6 In vitro studies also showed ASC differentiation
toward renal epithelium that could be induced by factors
secreted from renal tubular epithelial cells.24,25
Moreover, Brzoska et al.26 described an in vitro protocol
using ATRA in order to differentiate ASCs into epithelial cells
that expressed increased levels of the epithelial marker CK18
as well as decreased amounts of the mesenchymal marker
vimentin.
In the present study, ASCs cultured with ATRA gradually
increased the expression of different early nephrogenic
markers, such as Pax2, Wt1, Wnt4, Six2 and megalin. At the
same time, epithelial markers CK18 and E-CAD were
upregulated, whereas the mesenchymal marker vimentin
was significantly decreased (Figures 2 and 3). Most
interestingly, stem cell differentiation reflected the process
of kidney organogenesis during development. Therefore,
in vitro differentiation of stem cells might be expected to
mimic the expression pattern of differentiation markers of the
development from the intermediate mesoderm to the
metanephric mesenchyme, and finally to the renal epithe-
lium. ATRA treatment increases the expression of Pax2, one
of the first genes expressed during kidney embryogenesis in
the intermediate mesoderm and the first indicator of renal
lineage determination.27 ATRA-treated cells also express
Wt1 and Six2,28 which are the main transcription factors
expressed in nephron precursors, and are essential for
correct kidney formation during development. Wt1 is readily
upregulated in the metanephric mesenchyme together with
Wnt4,29 a component of the Wnt pathway, and both play a
crucial role during the transition of the mesenchyme to renal
epithelia.30 Furthermore, the membrane glycoprotein mega-
lin adopts a pivotal role in determining kidney functional
responses in renal epithelial cells. Stem cell differentiation
may also be monitored by determining epithelial versus
mesenchymal markers. During in vitro differentiation and
MET, epithelial markers CK18 Griesche et al.31 and E-CAD32
were described to be upregulated, whereas mesenchymal
markers such as vimentin33 were concomitantly down-
regulated. After treatment with ATRA, cells undergo significant
morphological changes. The typical fibroblastic, mesen-
chymal-like morphology of ASCs gradually changes toward
a more epithelial-like, polygonal morphology. These morpho-
logical and cytoskeletal changes represent the key process
during MET, allowing the cells to adopt the characteristic
epithelial cell apical–basal polarity.
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The let-7 family of miRNAs is classically involved in stem
cell differentiation.17,18 It was previously shown that miRNA
let-7, together with miRNA-24, adopts a specific role in
osteogenic differentiation through the PDGF pathway.17
Interestingly, miRNA let-7 is barely detectable in the embryo-
nic kidney, but is significantly expressed in the adult
kidney.16,34 Moreover, let-7 expression is clearly decreased
in pathophysiological states of cellular dedifferentiation such
as renal cell carcinoma.19 In our study, we were able to show
clearly that miRNA let-7e was significantly increased in ASCs
differentiated with ATRA in vitro (Figure 4). This increase was
concomitant with an increased expression of Pax2, Wt1,
Wnt4, megalin and CK18. In contrast, blocking of miRNA
let-7e in differentiated cells reversed these gene expression
patterns, indicating the involvement of miRNA let-7e in renal
epithelial cell differentiation.
MMPs play a key role in the differentiation of diverse tissues
and organs throughout the body.35 During renal organogen-
esis, MMP2 and MMP9 are mainly synthesized by renal
mesenchyma when the ureteric bud interacts with the
metanephric mesenchyme. Interestingly, only MMP9, but
not MMP2, was shown to play a crucial role during in vitro
renal organogenesis.9 MMP9 degrades denatured collagen
(gelatin), native collagen types I, IV, V and IX and elastin with
high specificity. Therefore, it was speculated that MMP9 is
involved in epithelial differentiation because of its role in
extracellular matrix remodeling, a central step inMET.9MMP9
also has the ability to degrade other nonstructural molecules
such as E-CAD as well as other cell-to-cell adhesion
molecules.36–38 Degradation of E-cadherin through MMP9
miRNAs promotes the process of epithelial-to-mesenchymal
transition and cellular dedifferentiation.36 Our results further
corroborate these findings, as addition of recombinant MMP9
to differentiated epithelial cells (from ASC or NRK-52e cell
line) significantly reduced the protein levels of E-CAD. In this
regard, the blocking of MMP9 may possibly be a key event in
the maintenance of the epithelial phenotype. We conclude
that MMPs are crucial players during differentiation in both
MET and EMT.9 Therefore, there is a strong need for tight
regulation of both the expression and activity of MMPs.
Regarding the regulation of MMP9, miRNAs have been
reported to act at the post-transcriptional level.39 Moreover,
MMP9 mRNA is classified in the miRWalk database as a
predicted target gene of miRNA let-7e,22 and a recent report
showed the indirect relationship of MMP9 andmembers of the
let-7 family through regulation of the MMP inducer basigin.20
Our results point rather to a direct interaction of miRNA let-7e
with MMP9 (Figure 6) shown by luciferase reporter assays
using full-length constructs of the 30UTR of MMP9 and
mutated constructs, deficient at the let-7e-binding site.
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Figure 5 miRNA let-7e influences the expression of early nephrogenic and epithelial markers. ATRA-treated cells were transfected with 100 nM antiLet-7e or control
antimir (CantimiR) at day 4 and collected at day 6. RT-PCR of ASCs transfected with 100 nM let-7e shows increased expression of PAX2, Wnt4 and WT1 compared with
control cells (C). miRNA let-7e silencing (þ antiLet-7e) reduces the expression of early nephrogenic markers PAX2, Wnt4, WT1, megalin and CK18 compared with control
antimiR-transfected cells (þCantimiR); n¼ 4. Data are means±S.D. *Po0.05 versus Cmimc; þPo0.05 versus CantimiR. mRNA expression levels were normalized to
GAPDH
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In summary, we found that miRNA let-7e adopts a pivotal
role during the differentiation of ASCs to epithelium. We
further characterized MMP9 as a direct target of miRNA let-
7e and obtained mechanistic insights into epithelial cell
differentiation from ASCs. To conclude, miRNA let-7e
induces ASC epithelial differentiation by modulating MMP9
expression.
Materials and Methods
Isolation and expansion of mouse ASCs. Male Swiss CD1 mice
(Charles River, Wilmington, MA, USA) were used for the extraction of subcutaneous
adipose tissue, as previously reported.40 All donors were 3–4 months old and were
killed by CO2 inhalation. ASCs were isolated from fat pads overlying the pelvis and
proximal femurs based on standard protocols.41 Briefly, fat pads were excised,
washed extensively with PBS containing 2% penicillin–streptomycin (Gibco, Life
Technologies, Madrid, Spain) and 0.5mg/ml amphotericin B (Gibco, Life
Technologies) and then minced using a scalpel. Minced fat tissue was digested
with collagenase Type IA (Sigma-Aldrich) for 1 h at 371C and 150 r.p.m. Following
digestion, the reaction was stopped with expansion medium and cell suspension was
centrifuged (400 g, 10 min). Floating material (adipocytes and fibrous material) was
discarded, and the cell pellet (stromal vascular fraction) was resuspended and filtered
through a 70mm cell strainer (BD Bioscience, Madrid, Spain). The stromal vascular
fraction was filtrated and recovered by a second centrifugation (400 g, 7 min).
Pellet was resuspended in expansion medium and cultured in a T175 plastic flask
(Greiner Bio-one, Frickenhausen, Germany). After 24 h, nonadherent cells were
removed and adherent cells containing ASCs were further expanded and passaged
before reaching 80% confluence.
Expansion culture consisted of DMEM with physiologic glucose concentration
(1000 mg/l; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS)
(Gibco, Life Technologies) and 1% penicillin–streptomycin.
Multilineage differentiation potential: adipogenic and osteo-
genic differentiation protocol. For adipogenic differentiation, ASCs were
cultured in 12-well plastic plates, seeded at a density of 22 000 cells/cm2 and then
cultured for 2 weeks in a-MEM medium (PAA, Pasching, Austria) supplemented
with 10% FBS, 1 mM dexamethasone (Sigma-Aldrich) and 320 nM insulin (Sigma-
Aldrich). ASCs were stained with 0.2% Oil Red O reagent (Sigma-Aldrich) for lipid
detection.41 For osteogenic differentiation, ASCs were cultured in 12-well plastic
plates seeded at a density of 4200 cells/cm2 and then cultured for 20 days in
a-MEM medium (PAA) supplemented with 10% FBS, 10 nM dexamethasone
(Sigma-Aldrich), 200mM ascorbate-2-phosphate (Sigma-Aldrich) and 10 mM
b-glycerophosphate (Sigma-Aldrich). ASCs were stained with 2% Alizarin red
(Sigma-Aldrich) to detect matrix mineralization.23
Flow cytometry. Flow cytometric characterization of ASCs (passage 3) was
performed as previously reported42,43 for the surface markers Sca-1, CD44, CD29,
CD45 and CD34. These markers were selected in accordance with previously
published studies.44,45 Briefly, ASCs were trypsinized, washed with PBS and
centrifuged at 400 g for 5 min. Cell aliquots (2 105) were then blocked with
goat serum for 30 min at 41C and resuspended in 100ml of PBS/BSA buffer.
Finally, anti-mouse antibodies FITC-Sca1 (AbD Serotec, Oxford, UK), FITC-CD29
(AbD Serotec), FITC-CD34 (AbD Serotec), PE-CD44 (Southern Biotech,
Birmingham, AL, USA), Alexa fluor700-CD45 (AbD Serotec) and their respective
isotype controls were added and incubated for 30 min at RT. Propidium iodide (PI)
staining (Sigma-Aldrich) was performed (1 mg/ml) in order to check cell viability.
Detection was performed on a FACS canto II cytometer (BD Bioscience).
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Figure 6 miRNA let-7e targets MMP9 in ASCs during differentiation. (a) Untreated ASCs transfected with 100 nM let-7e (þ let-7e) downregulate the expression of MMP9
mRNA measured by qRT-PCR; n¼ 4. Data were normalized to GAPDH. Results are expressed as mean±S.D. *Po0.05 versus þControl. (b) Gelatin zymography of
supernatants 24 h after transfection with let-7e (100 nM) or control oligonucleotides. (c) miRNA let-7e targets the mouse MMP9 30UTR in HEK293 cells, (d) miRNA let-7e
targets the mouse MMP9 30UTR in untreated ASCs and in ASCs undergoing differentiation with ATRA. Cells were transfected either with the control vector (Control), a wild-
type construct (30UTR-MMP9) with an intact let-7e-binding site or the mutated construct (30UTR-mutMMP9), as indicated. Cells were co-transfected with either control miRNA
(c), miRNA let-7e (þ let-7e), control antimiR (CantimiR) or anti-let-7e (þ antiLet-7), respectively. Relative luciferase activity was measured by determining firefly and Renilla
luciferase. Data are expressed as % of luciferase activity; n¼ 4. Data are means±S.D. *Po0.05 versus Control
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Epithelial differentiation. For epithelial differentiation, ASCs (passage 3)
were cultured with ATRA (Sigma-Aldrich) at a final concentration of 5mM as
previously described.26 ATRA was dissolved in low glucose (100 mg/dl) DMEM
medium supplemented with 10% FBS and antibiotics. Medium was replaced every
3 days during a total period of 11 days, followed by analysis of the resulting cell
population and evaluation of the morphology.
miRNA transfection. Transfections of ASCs with 100 nM let-7e (50-UGAGG
UAGGAGGUUGUAUAGUU-30; Dharmacon, Madrid, Spain), 100 nM LNA-anti-let-
7e (50–ACTATACAACCTCCTACCTC-30; Exiqon, Vedbaek, Denmark) or the
respective negative controls were carried out using Lipofectamine 2000
(Invitrogen, Madrid, Spain) according to the manufacturer’s instructions. Medium
was replaced after 6 h of transfection. Transfection times are described in
Figure 4.
RNA extraction, reverse transcription mRNA and RT-PCR. Total
RNA was extracted using TRIZOL reagent (Invitrogen). Then, 1mg of total RNA
was reverse transcribed using an iScript cDNA synthesis kit (Bio-Rad, Hercules,
CA, USA). The qRT-PCRs were performed using either TaqMan Universal PCR
Master Mix (Applied Biosystems, Madrid, Spain) or iQ SYBR Green Supermix
(Bio-Rad) depending on the primer used. Mouse primers provided by Applied
Biosystems and Qiagen (Madrid, Spain) were previously validated (GAPDH, SIX2,
PAX2, MMP9, WT1, WNT4, vimentin and megalin). CK18 (forward: 50-CAGT
ATGAAGCGCTGGCTCAGA-30, reverse: 50-CGGCAGACTTGGTGGTGA-30) and
E-CAD (forward: 50-TGAAGAAGGAGGTGGAGAAGAAGA-30, reverse: 50-TGGGA
GCCACATCATTTCGA-30) were bought from Invitrogen. Results were normalized
to glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
miRNA target site prediction. miRNA sequences were retrieved from the
miRBase database and prediction of putative target mRNAs were analyzed using
the miRWalk database.22
Reverse transcription and RT-PCR of microRNA. Total RNA was
extracted as described before, and specific reverse transcription for miRNA
mmu-let-7e and U6 small nuclear RNA (U6 snRNA) was performed using TaqMan
microRNA Assay (Applied Biosystems). qRT-PCR was performed using the
TaqMan Universal PCR Master Mix (Applied Biosystems) and primers were
provided by Applied Biosystems. Results were normalized to U6 snRNA.
Immunocytochemistry. Immunocytochemistry was performed at the time
when the differentiation markers reached their maximum expression (day 11).
Cells were fixed in 4% paraformaldehyde for 15 min at RT, washed twice with
PBS and fixed in ice cold acetone for 5 min. ASCs were then blocked in 1% BSA in
PBS-T for 30 min at RT, followed by overnight incubation at 41C with rabbit anti-
cytokeratin 18 (Millipore, Darmstadt, Germany ). A non-immune immunoglobulin of
the same isotype as the primary antibody was used as a control for
immunocytochemistry (Millipore). The secondary antibody (goat biotinylated anti-
rabbit IgG; Vector Laboratories) was incubated for 1 h at RT. Samples were stained
using the avidin-peroxidase conjugate method for 1 h. Cellular nuclei were
counterstained with hematoxylin (Sigma-Aldrich).
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Figure 7 MMP9 is involved in ASC differentiation with ATRA. (a) In situ zymography for MMP9. The left column panel shows the increased gelatinolytic activity in ASCs
cultured with ATRA and silenced at day 4 with 100 nM antiLet-7e (ATRAþ antiLet-7e) with respect to ASCs transfected with a control oligonucleotide (ATRAþCantimiR). The
middle column panel indicates the results obtained when ASCs were incubated for 1 h with FITC-labeled DQ-gelatin. Green dots represent gelatinolytic activity of cultured
cells. Results show an increase in gelatinolytic activity in silenced cells (ATRAþ antiLet-7e). Magnification  20 (middle panel). Magnification  40 (right panel). A negative
control was included by incubating the cells with 20 mM EDTA. (b) In two different kinds of epithelial cells, epithelial differentiated ASCs (left panel) and in renal epithelial cell
line NRK-52e after addition of recombinant MMP9 (2mg/ml and incubated for 72 h), western blot analysis of E-cadherin indicates a reduction in E-cadherin protein expression
after MMP9 addition in the two cell lines. Equal loading was controlled by b-actin expression. A representative picture from four experiments is shown. ASCs treated with ATRA
showed a significant increase in E-cadherin expression compared with untreated cells. This increase could be blocked by the addition of recombinant MMP9 (ATRAþMMP9).
Addition of recombinant MMP9 to ASCs (ATRAþMMP9) or NRK cells (þMMP9) decreased E-cadherin expression
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DAPI and phalloidin staining. DAPI and phalloidin staining was
performed on day 11, when the differentiation markers reached their maximum
expression. Cells were washed with PBS, fixed in 4% paraformaldehyde for 10 min
at RT and permeabilized with ice cold acetone for 5 min. Cells were blocked in
goat serum for 1 h at RT and then stained with Alexa Fluor 568 phalloidin
(Invitrogen) in 1% PBS/BSA for 30 min. Nuclei were visualized by the addition of
DAPI solution (0.2mg/ml) for 5 min at RT.
Dual luciferase reporter gene constructs. The vector constructs
were commercially available and obtained from GeneCopoeia (Rockville, MD,
USA): control vector (pEzX-MT01) and reporter construct containing the 30UTR of
mouse MMP9 (pEzX-MT01-MMP9 30UTR). A deletion for the let-7e predicted
binding site was obtained using the QuickChange II XL site-directed mutagenesis
kit (Stratagene, Santa Clara, CA, USA). The correct sequences were confirmed by
sequencing. PEzX-MT01 vectors use firefly luciferase as reporter gene under the
control of a SV40 promoter and Renilla luciferase as tracking gene under the
control of a CMV promoter.
Luciferase assay. A total of 90 000 HEK293 cells (very easy to transfect)
were used and transiently transfected with 0.1mg of vector constructs using
Lipofectamine 2000 (Invitrogen) for 6 according to the manufacturer’s instructions.
Cells were co-transfected with 100 nM miRNA let-7e or the respective negative
control.
A total of 22 000 ASCs were cultured in 12-well plates and differentiated for 1–11
days. Cells were transfected at different days of the culture with 1mg of vector
constructs using Nanojuice transfection reagent (Novagen, Darmstadt, Germany)
according to the manufacturer’s instructions. Cells were co-transfected as indicated
with 100 nM miRNA let-7e, LNA-antiLet-7e or the respective negative controls. After
transfection, cells were lysed with 1 passive lysis buffer (Promega, Madison, WI,
USA) and luciferase activities were measured as light emission after addition of
Renilla and Firefly luciferase substracts using a luminometer (Mithras, Berthold
Technologies, Bad Wildbad, Germany). Firefly luciferase activity was normalized to
Renilla luciferase activity in the cell lysate. The background obtained from cells
treated with Lipofectamine but without the vector construct (mock-transfected cells)
was subtracted from each experimental value.
Gelatin zymography. Supernatants of ASCs were collected 24 h after
transfection with let-7e, and 1 ml of each sample was used for gelatin zymography
experiments to evaluate MMP9 activity. Supernatants were incubated with 50 ml of
gelatin-sepharose 4B (GE Healthcare, Barcelona, Spain) under constant shaking
at 41C for 1 h and centrifuged at 500 g for 2 min at 41C. The resulting pellet
containing gelatinases was washed by centrifugation at 500 g for 2 min at 41C
before separation of gelatinases with elution buffer by incubation at 41C under
constant shaking for 30 min. Gelatinase fraction (1 : 1) was dissolved in Laemmli
sample buffer (Bio-Rad) and loaded on gels containing 8% acrylamide and porcine
gelatin (1 mg/ml). After electrophoresis, gels were incubated with 250 ml of buffer
containing 50 mM Tris–HCl, pH, 7.5, 10 mM CaCl2 and 0.02% NaN3, for 24 h at
371C in order to activate gelatinases. After incubation, gels were stained with 0.1%
amido black (naphthol blue black, Sigma-Aldrich) in acetic acid/methanol/water
(1 : 3 : 6) for 30 min. Then, gels were unstained by immersing in acetic acid/
methanol/water (1 : 3 : 6) for 30 min. To determine gelatinase activity, gels were
scanned in a densitometer and relative activity levels were analyzed with digital
image analysis using Quantity one 4.5.1 Software (Bio-Rad).
In situ zymography. In situ zymography was performed as previously
described.46 ASCs were cultured with ATRA and incubated with 10 mg/ml of FITC-
labeled DQ-gelatin (Molecular Probes, Eugene, OR, USA) for 1 h at RT. Then,
cells were washed with PBS and counterstained with Hoechst 33258 dye. Green
FITC fluorescence indicative of gelatinase activity was observed using
fluorescence microscopy (Leica, Solms, Germany). Negative control was
performed using 20 mM EDTA.
Recombinant MMP9 treatment. The role of MMP9 in E-CAD degradation
was studied in mature epithelial cells such as NRK52E kidney tubular epithelial
cells or in ASCs differentiated to epithelial cells.
NRK52E kidney tubular epithelial cells and ASCs after 8 days of differentiation
were treated for 3 days with mouse recombinant MMP9 protein (Abcam,
Cambridge, UK) as previously reported (2mg/ml),36 in order to obtain samples
at day 11.
Western blot. ASCs were lysed in RIPA buffer (150 mM NaCl, 1% NP-40,
0.1% SDS, 50 mM Tris-base, 0.5% sodium deoxycholate containing 1 mM PMSF
and 5 mM EDTA) at 41C. Protein concentration was measured using Bradford
(Bio-Rad). Then, 20mg of total protein was electrophoresed on 10% SDS-
polyacrylamide gels and transferred on nitrocellulose membranes. Membranes
were incubated overnight at 41C with the following primary antibodies: anti-E-
cadherin (Santa Cruz, Dallas, TX, USA) and anti-b-Actin (Sigma-Aldrich).
Membranes were then incubated for 1 h at RT with horseradish peroxidase-
conjugated anti-rabbit IgG (Sigma-Aldrich), followed by ECL detection. Equal
protein loading was verified by immunoblotting for b-actin.
Statistical analysis. Data are expressed as means±S.D. Means of different
groups were compared using one-way ANOVA. The Student–Newman–Keuls test
was used for the evaluation of significant differences between groups. The
existence of significant differences was assumed when Po0.05.
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